Renal protection in chronic heart failure: focus on sacubitril/valsartan

Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF) and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence supporting the effectiveness of angiotensin-converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers, and mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pontremoli, Roberto, Borghi, Claudio, Perrone Filardi, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453284/
https://www.ncbi.nlm.nih.gov/pubmed/33822031
http://dx.doi.org/10.1093/ehjcvp/pvab030

Ejemplares similares

Ejemplares similares